Related Experiment Video

Updated: Jun 7, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms

Marco Tartaglia1, Bruce D Gelb

  • 1Dipartimento di Ematologia, Oncologia e Medicina Molecolare, Istituto Superiore di Sanità, Rome, Italy. mtartaglia@iss.it

Annals of the New York Academy of Sciences
|October 21, 2010
PubMed

Insights

Germline mutations in RAS GTPases and related proteins cause developmental disorders by disrupting the RAF-MEK-ERK signaling pathway. This overview details the phenotypic spectrum, molecular mechanisms, and genotype-phenotype correlations of these RASopathies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • RAS GTPases regulate critical cellular functions, including proliferation and differentiation.
  • The RAF-MEK-ERK pathway (a mitogen-activated protein kinase cascade) is central to development and growth.
  • Dysregulation of RAS-MAPK signaling is implicated in oncogenesis.

Purpose of the Study:

  • To review the phenotypic spectrum of disorders caused by germline mutations in the RAS-MAPK pathway.
  • To explore the molecular mechanisms underlying RAS-MAPK pathway dysregulation in inherited conditions.
  • To examine genotype-phenotype correlations in RASopathies.

Main Methods:

  • Literature review of studies on RASopathies and RAS-MAPK signaling.
  • Analysis of genetic mutations affecting RAS proteins, regulators, and downstream effectors.
  • Correlation of genetic findings with clinical phenotypes.

Main Results:

  • Inherited mutations in RAS pathway components lead to a spectrum of disorders (RASopathies).
  • These disorders share features like facial dysmorphism, cardiac defects, and developmental issues.
  • Mutations affect RAS proteins, their regulators, or downstream signal transducers, causing pathway hyperactivation.

Conclusions:

  • Germline mutations in the RAS-MAPK pathway cause a distinct group of developmental disorders.
  • Understanding these RASopathies reveals crucial roles of RAS signaling in human development.
  • Further research into genotype-phenotype correlations can guide clinical management and therapeutic strategies.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: